Olah Inhibitors
Chemical inhibitors of Olah can play a significant role in modulating its activity through various signaling pathways by directly targeting the enzymes that regulate these pathways. Bisindolylmaleimide and Gö6976 are both inhibitors of Protein Kinase C (PKC), which suggests that they can reduce the activity of Olah if it is regulated by PKC-mediated phosphorylation. Staurosporine has a broader kinase inhibition profile, capable of inhibiting numerous protein kinases, and hence can decrease Olah activity if it is subject to regulation by any of these kinases. LY294002 and Wortmannin are inhibitors of the PI3K/Akt pathway, which implies they can suppress Olah activity if it is downstream of PI3K signaling. Rapamycin, by inhibiting mTOR, which is central to cell growth and survival pathways, can also decrease the activity of Olah if it is involved in or regulated by the mTOR pathway.
In the context of the MAPK/ERK pathway, both PD98059 and U0126 serve as MEK inhibitors, which means they can inhibit Olah if its activity is contingent upon MEK-mediated signaling. Similarly, SB203580, which inhibits p38 MAPK, can reduce the activity of Olah if the p38 MAPK pathway modulates it. The JNK pathway inhibitor SP600125 can suppress Olah activity by blocking JNK-mediated phosphorylation signals if Olah function depends on JNK signaling. Y-27632 inhibits ROCK kinase, suggesting that it can reduce Olah activity if regulated by the Rho/ROCK pathway. NF449, a selective inhibitor of the Gs-alpha subunit of G-proteins, implies that it can decrease Olah activity if Olah is regulated by G-protein-coupled receptor signaling through the Gs-alpha subunit. These chemical inhibitors, each targeting different regulatory kinases, provide a diverse toolkit for influencing the activity of Olah depending on its specific regulatory pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is known to inhibit Protein Kinase C (PKC), which is involved in signaling pathways that can regulate the activity of various proteins including Olah. Inhibition of PKC can thus lead to decreased Olah function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of many protein kinases, and if Olah's function is regulated by phosphorylation through such kinases, staurosporine could reduce Olah activity by preventing its phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This chemical is an inhibitor of PI3K, a kinase that participates in the Akt signaling pathway. If Olah activity is downstream of PI3K/Akt signaling, LY294002 can inhibit this pathway, potentially reducing Olah activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central component of a cell growth and survival pathway. If Olah functions within this pathway or is regulated by it, rapamycin could result in the functional inhibition of Olah. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound inhibits MEK, which is involved in the MAPK/ERK pathway. If Olah activity is regulated by this pathway, PD98059 could lead to the inhibition of Olah by preventing its activation through this route. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, and like PD98059, it would inhibit Olah by impeding the MAPK/ERK pathway if Olah's activity is contingent upon signaling through this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This chemical is an inhibitor of p38 MAPK. If Olah activity is modulated by the p38 MAPK pathway, SB203580 could inhibit Olah by blocking this specific signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK. If the function of Olah is dependent on JNK signaling, this inhibitor could suppress Olah activity by impeding the phosphorylation signals mediated by JNK. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor like LY294002. It would inhibit Olah by blocking the PI3K/Akt pathway if Olah is implicated in this signaling cascade. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This chemical is a selective inhibitor of ROCK kinase. If the activity of Olah is regulated by the Rho/ROCK pathway, Y-27632 could inhibit this pathway and therefore decrease the activity of Olah. | ||||||